Using Skindex-29 Scale to Assess the Impact of Androgenetic/Patterned Hair Loss on Quality of Life of Patients in Pakistan

February 2022 in “ Pakistan Armed Forces Medical Journal ”

Sakina Sadiq, Tehseen Naveed, Safoora Naveed, Irfan Jamil Minhas, Bushra Tayyaba Khan, Sunniya Sadiq

androgenetic alopecia female patterned hair loss Skindex-29 quality of life alopecia AGA FPHL

TLDR Hair loss significantly affects quality of life, especially for women, in Pakistan.

The study "Using Skindex-29 Scale to Assess The Impact of Androgenetic/Patterned Hair Loss on Quality of Life of Patients in Pakistan" involved 300 patients (150 males and 150 females) with androgenetic alopecia (AGA)/female patterned hair loss (FPHL). The Skindex-29 questionnaire was used to assess the impact of alopecia on their quality of life. The mean age of participants was 41.6 ± 12.4 years, with most patients (40.7%) having grade-1 severity of alopecia and a disease duration of 1-5 years (37.3%). The study found that gender and disease duration were statistically significant (p=0.001 and p=0.013 respectively) in affecting the quality of life. The Skindex-29 scale was found to be effective in assessing the quality of life in AGA/FPHL patients, with females being more severely affected than males.

View this study on pafmj.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Why is it that low testosterone causes hair loss as well? How can I be balding?

in Chat 158 upvotes 8 months ago

The conversation discusses the confusion over low testosterone potentially causing hair loss, with users sharing personal experiences and knowledge about hair loss treatments like Finasteride. Some users suggest that hair follicle sensitivity to DHT, not testosterone levels, is the key factor in balding, and others discuss the side effects of hair loss medications.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

Related Research

7 / 7 results

research Hair Loss

August 2021 in “Pharmacy Today”

The document's conclusion about hair loss cannot be determined.

research Diffuse Hair Loss

June 2021 in “Elsevier eBooks”

The document's conclusion cannot be summarized because it is not readable or understandable.

research Treatment of Female Pattern Hair Loss with Combination Therapy

2 citations, November 2018 in “Seminars in Cutaneous Medicine and Surgery”

Combining different treatments works best for female hair loss.

research A Review on Hair Loss and Damage

January 2016

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

research Common Patterns and Etiologic Factors of Hair Loss for Women in Karak Governorate, Jordan

January 2015 in “Rawal Medical Journal”

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

research Viviscal: An Answer for Hair Loss in Women?

August 2013 in “Pharmacy Today”

Viviscal may modestly improve hair loss in women without adverse effects.

research Drugs and Hair Loss: Mechanisms and Clinical Implications

54 citations, September 2012 in “Dermatologic Clinics”

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.